Eaton Vance Management’s Accelerate Diagnostics AXDX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q3 | $339K | Hold |
22,322
| – | – | ﹤0.01% | 1404 |
|
|
2022
Q2 | $222K | Hold |
22,322
| – | – | ﹤0.01% | 1509 |
|
|
2022
Q1 | $321K | Hold |
22,322
| – | – | ﹤0.01% | 1617 |
|
|
2021
Q4 | $1.17M | Hold |
22,322
| – | – | ﹤0.01% | 1150 |
|
|
2021
Q3 | $1.3M | Hold |
22,322
| – | – | ﹤0.01% | 1026 |
|
|
2021
Q2 | $1.8M | Hold |
22,322
| – | – | ﹤0.01% | 1036 |
|
|
2021
Q1 | $1.86M | Hold |
22,322
| – | – | ﹤0.01% | 993 |
|
|
2020
Q4 | $1.69M | Hold |
22,322
| – | – | ﹤0.01% | 961 |
|
|
2020
Q3 | $2.38M | Hold |
22,322
| – | – | ﹤0.01% | 798 |
|
|
2020
Q2 | $3.38M | Hold |
22,322
| – | – | 0.01% | 687 |
|
|
2020
Q1 | $1.86M | Hold |
22,322
| – | – | ﹤0.01% | 771 |
|
|
2019
Q4 | $3.77M | Hold |
22,322
| – | – | 0.01% | 691 |
|
|
2019
Q3 | $4.15M | Hold |
22,322
| – | – | 0.01% | 633 |
|
|
2019
Q2 | $5.11M | Hold |
22,322
| – | – | 0.01% | 579 |
|
|
2019
Q1 | $4.69M | Hold |
22,322
| – | – | 0.01% | 569 |
|
|
2018
Q4 | $2.57M | Hold |
22,322
| – | – | 0.01% | 657 |
|
|
2018
Q3 | $5.12M | Hold |
22,322
| – | – | 0.01% | 543 |
|
|
2018
Q2 | $4.98M | Sell |
22,322
-22,321
| -50% | -$4.98M | 0.01% | 528 |
|
|
2018
Q1 | $10.2M | Buy |
44,643
+22,321
| +100% | +$5.1M | 0.01% | 512 |
|
|
2017
Q4 | $5.85M | Hold |
22,322
| – | – | 0.01% | 485 |
|
|
2017
Q3 | $5.01M | Buy |
+22,322
| New | +$5.01M | 0.01% | 506 |
|